UNSPSC 51411703: Ciclosidomine

This classification denotes a vasodilating agent and nitric oxide-releasing compound, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S7P608OW2O. European Medicines Agency schedules Ciclosidomine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06249MIG. Ciclosidomine generally arises in the molecular formula C13H20N4O3.

UNSPSC 51411703 Ciclosidomine, a Commodity code, represents emergency medical medications procured by state and local fire and rescue services for advanced life support protocols. The scope of work under this code encompasses emergency medications such as vasopressors, antiarrhythmics, and beta-blockers supplied to first-responder agencies for field deployment. State and local health and emergency services departments—particularly fire departments with paramedicine capabilities—issue procurement for these medications, which must meet strict expiration, warranty, and regulatory standards including OSHA Hazard Communication compliance and accessible documentation requirements. Vendors supply specified quantities of individual medication formulations with firm pricing inclusive of shipping, delivery within short windows (typically ten calendar days), and replacement protocols for expired stock before end-of-shelf-life.

The City of Tampa's Purchasing Department issued an IFB (Bid No. 26-P-00188) in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue with four medication line items—Labetalol HCI, Epinephrine, Adenosine, and Diltiazem—in quantities totaling approximately 3,530 units, with an estimated contract value of $40,000 and a one-year term renewable for two additional years at mutual agreement. The solicitation offered a 5 percent SLBE bid discount not to exceed $10,000 for Small Local Business Enterprise participation. No other state or local opportunities under this code appear in the recent data, limiting visibility into geographic concentration or frequency of issuance across jurisdictions. The single identified opportunity signals steady municipal procurement of emergency medications through local sealed-bid processes, though activity frequency or volume patterns under the code remain unclear from available records.